# Clinical Cases: Potassium Homeostasis ## Case 1: Diuretic-Induced Hypokalemia ### Patient Presentation A 68-year-old female with hypertension presents to her primary care physician with progressive weakness, muscle cramps, and fatigue over the past 3 weeks. She was started on hydrochlorothiazide 25 mg daily 6 weeks ago for blood pressure control. ### History of Present Illness - Progressive generalized weakness over 3 weeks - Muscle cramps, particularly in the legs at night - Fatigue and palpitations - Mild constipation - No vomiting or diarrhea - Compliant with low-sodium diet ### Physical Examination - Blood pressure: 128/78 mmHg (improved from 158/94) - Heart rate: 88 bpm, irregular - Decreased deep tendon reflexes - Mild muscle tenderness in calves - No edema ### Workup **Laboratory Studies:** - Serum potassium: 2.6 mEq/L (severely low) - Serum magnesium: 1.3 mg/dL (low) - Bicarbonate: 32 mEq/L (elevated - metabolic alkalosis) - Creatinine: 1.0 mg/dL - Urine potassium: 48 mEq/day (inappropriately elevated for hypokalemia) **ECG:** - Flattened T waves - Prominent U waves in precordial leads - Occasional premature ventricular contractions ### Diagnosis **Thiazide Diuretic-Induced Hypokalemia with Hypomagnesemia** ### Discussion This case illustrates key concepts from the lecture on potassium homeostasis: - **Mechanism of Thiazide-Induced Hypokalemia**: The lecture explains that increased sodium delivery to the collecting duct enhances potassium secretion. Thiazides block sodium reabsorption in the DCT, delivering more sodium downstream where aldosterone-mediated exchange occurs. - **Urine Potassium Interpretation**: Despite hypokalemia, urine potassium remains elevated (>20 mEq/day), indicating inappropriate renal potassium wasting rather than extrarenal losses. - **Metabolic Alkalosis**: Hypokalemia and alkalosis reinforce each other - the alkalosis promotes potassium secretion while hypokalemia increases acid excretion. - **Magnesium Depletion**: The lecture emphasizes that hypomagnesemia causes refractory hypokalemia and must be corrected for potassium levels to normalize. ### Treatment - Oral potassium chloride 40 mEq twice daily - Magnesium oxide 400 mg twice daily (essential - K won't normalize without Mg correction) - Consider switching to potassium-sparing diuretic or adding amiloride - Recheck electrolytes in 1 week - Dietary counseling on potassium-rich foods ### Clinical Pearl In diuretic-induced hypokalemia, always check magnesium levels. Hypomagnesemia increases ROMK channel activity and enhances renal potassium wasting. Potassium repletion will fail until magnesium is corrected. --- ## Case 2: Hyperkalemia in Diabetic Kidney Disease ### Patient Presentation A 62-year-old male with type 2 diabetes and stage 4 CKD (eGFR 22 mL/min) presents to the emergency department after his cardiologist noted "tall T waves" on a routine ECG. He reports no symptoms. ### History of Present Illness - Routine cardiology follow-up for stable coronary artery disease - ECG changes prompted immediate ED referral - No chest pain, palpitations, or weakness - Medications: lisinopril 20 mg, metoprolol 50 mg, spironolactone 25 mg, empagliflozin 10 mg - Recently started on ibuprofen 600 mg TID for knee osteoarthritis ### Physical Examination - Blood pressure: 142/88 mmHg - Heart rate: 58 bpm, regular - No peripheral edema - Normal strength throughout - Alert and oriented ### Workup **Laboratory Studies:** - Serum potassium: 6.8 mEq/L (severely elevated) - Creatinine: 2.8 mg/dL (baseline 2.4) - BUN: 48 mg/dL - Bicarbonate: 18 mEq/L (low - metabolic acidosis) - Glucose: 168 mg/dL **ECG:** - Peaked, narrow T waves - PR interval 240 ms (prolonged) - QRS 110 ms (borderline widened) - No P wave loss or sine wave pattern ### Diagnosis **Severe Hyperkalemia due to Type 4 RTA and Multiple Contributing Medications** ### Discussion This case demonstrates multiple mechanisms of hyperkalemia: - **Type 4 RTA (Hyporeninemic Hypoaldosteronism)**: Common in diabetic nephropathy. The lecture explains that hyperkalemia inhibits renal ammoniagenesis, reducing net acid excretion and causing the mild metabolic acidosis typical of type 4 RTA. - **Medication Contributions**: Multiple drugs that raise potassium - lisinopril (ACE inhibitor reduces aldosterone), spironolactone (blocks mineralocorticoid receptor), metoprolol (beta-blocker impairs cellular potassium uptake), ibuprofen (NSAID reduces prostaglandin-mediated renin release and directly affects potassium secretion). - **ECG Changes**: The lecture describes the progression of ECG changes - peaked T waves appear first (5.5-6.5 mEq/L), followed by PR prolongation and QRS widening (6.5-7.5 mEq/L). - **Pseudohyperkalemia Excluded**: The patient has no hemolysis, thrombocytosis, or leukocytosis, and ECG changes confirm true hyperkalemia. ### Treatment **Immediate Management:** - Calcium gluconate 10 mL of 10% IV over 2-3 minutes (membrane stabilization) - Regular insulin 10 units IV with 25 g dextrose (shift potassium intracellularly) - Sodium bicarbonate 50 mEq IV for the acidosis - Continuous cardiac monitoring **Subsequent Management:** - Discontinue spironolactone and ibuprofen - Hold lisinopril temporarily - Sodium polystyrene sulfonate 30 g orally - Consider dialysis if refractory - Potassium-restricted diet ### Clinical Pearl The combination of ACE inhibitor, mineralocorticoid receptor antagonist, and NSAID in a patient with CKD and diabetes represents a "perfect storm" for hyperkalemia. Each medication alone may be tolerated, but together they can precipitate life-threatening hyperkalemia. --- ## Case 3: Diabetic Ketoacidosis with Potassium Shifts ### Patient Presentation A 24-year-old female with type 1 diabetes presents with nausea, vomiting, and abdominal pain for 24 hours. She ran out of insulin 3 days ago. ### History of Present Illness - Progressive nausea and vomiting for 24 hours - Diffuse abdominal pain - Profound thirst and frequent urination - Unable to afford insulin refill - Reports Kussmaul respirations and fruity breath odor noted by family ### Physical Examination - Blood pressure: 98/62 mmHg - Heart rate: 118 bpm - Respiratory rate: 28/min, deep (Kussmaul respirations) - Dry mucous membranes, decreased skin turgor - Fruity breath odor - Diffuse abdominal tenderness without peritoneal signs - Drowsy but arousable ### Workup **Initial Laboratory Studies:** - Serum potassium: 5.8 mEq/L (high-normal/elevated) - Serum glucose: 485 mg/dL - Serum bicarbonate: 8 mEq/L - Arterial pH: 7.12 - Anion gap: 28 - Creatinine: 1.6 mg/dL - Beta-hydroxybutyrate: 8.2 mmol/L (markedly elevated) **After 2 Hours of Insulin Infusion:** - Serum potassium: 3.4 mEq/L (dropping rapidly) - Serum glucose: 320 mg/dL - pH: 7.22 (improving) ### Diagnosis **Diabetic Ketoacidosis with Internal Potassium Redistribution** ### Discussion This case illustrates the critical concept of internal versus external potassium balance: - **Initial "Normal" Potassium is Misleading**: The lecture explains that despite a serum potassium of 5.8 mEq/L, this patient has severe total body potassium depletion from osmotic diuresis. The normal or elevated serum value reflects transcellular shifts, not adequate stores. - **Mechanisms of DKA Hyperkalemia**: Insulin deficiency reduces Na+/K+-ATPase activity, impairing cellular potassium uptake. Hyperosmolality causes water to leave cells, carrying potassium by solvent drag. The mineral acidosis (ketoacidosis has both mineral and organic acid components) causes hydrogen-potassium exchange. - **Rapid Correction Risk**: When insulin is administered, potassium shifts rapidly into cells. The lecture emphasizes monitoring closely and replacing potassium early to prevent life-threatening hypokalemia during DKA treatment. - **Total Body Depletion**: The osmotic diuresis from glucosuria causes massive urinary potassium losses, depleting total body potassium by 3-5 mEq/kg despite the elevated serum level. ### Treatment - IV fluid resuscitation with normal saline - Continuous insulin infusion (0.1 units/kg/hour) - Add potassium chloride 40 mEq/L to IV fluids when K+ falls below 5.2 mEq/L - Monitor potassium every 1-2 hours during treatment - Transition to subcutaneous insulin and oral intake when anion gap closes - Social work referral for insulin access ### Clinical Pearl In DKA, the initial serum potassium does not reflect total body stores. Patients typically have 300-600 mEq total body potassium deficit despite normal or elevated serum levels. Add potassium to IV fluids early (once K+ <5.2 mEq/L and urine output is confirmed) to prevent precipitous drops during insulin therapy. --- ## Image Reference For visual reference of potassium homeostasis concepts, see: - Wikimedia Commons: [Potassium homeostasis](https://commons.wikimedia.org/wiki/Category:Potassium) - Diagrams of cellular distribution - Radiopaedia: [Hyperkalemia ECG changes](https://radiopaedia.org/articles/hyperkalaemia-ecg-changes) - Characteristic ECG progression - Radiopaedia: [Hypokalemia ECG changes](https://radiopaedia.org/articles/hypokalaemia-ecg-changes) - U waves and T wave flattening --- ## Learning Points 1. **Urine Potassium Distinguishes Causes**: Urine K+ <20 mEq/day indicates extrarenal losses (GI, shift); >20 mEq/day indicates renal wasting. 2. **Magnesium is Essential**: Hypomagnesemia causes refractory hypokalemia through increased ROMK activity; always check and correct Mg. 3. **DKA Potassium Paradox**: Total body potassium is depleted despite normal or high serum levels; anticipate rapid drops with insulin. 4. **ECG Guides Urgency**: Peaked T waves, PR prolongation, and QRS widening indicate need for immediate calcium gluconate regardless of exact potassium level. 5. **Medication Review Critical**: Multiple drugs affecting potassium (ACE inhibitors, ARBs, K+-sparing diuretics, NSAIDs, beta-blockers) can cause dangerous hyperkalemia when combined in susceptible patients.